immunology elusive aids vaccine 
developing human immunodeficiency virus hiv vaccine critical end global acquired immunodeficiency syndrome aids epidemic many question whether goal achievable natural immunity protective despite immunogenicity hiv vaccine candidates human trials exclusively yielded disappointing results nevertheless indication success may possible will dependent understanding antiviral immune response unprecedented depth identify engineer types immunity required outline fundamental immunological questions need answered develop protective hiv vaccine immediate need harness much broader scientific community achieve goal 
